These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 1928065

  • 1. C1q nephropathy: a pediatric clinicopathologic study.
    Iskandar SS, Browning MC, Lorentz WB.
    Am J Kidney Dis; 1991 Oct; 18(4):459-65. PubMed ID: 1928065
    [Abstract] [Full Text] [Related]

  • 2. Predominant but silent C1q deposits in mesangium on transplanted kidneys - long-term observational study.
    Kanai T, Akioka Y, Miura K, Hisano M, Koike J, Yamaguchi Y, Hattori M.
    BMC Nephrol; 2018 Apr 06; 19(1):82. PubMed ID: 29625558
    [Abstract] [Full Text] [Related]

  • 3. C1q nephropathy in India: a single-center study.
    Kanodia KV, Vanikar AV, Patel RD, Suthar KS, Patel HV, Gumber MA, Shah PR, Trivedi HL.
    Saudi J Kidney Dis Transpl; 2015 Mar 06; 26(2):398-403. PubMed ID: 25758901
    [Abstract] [Full Text] [Related]

  • 4. Clinical and immunopathologic study of mesangial IgM nephropathy: report of 41 cases.
    Hsu HC, Chen WY, Lin GJ, Chen L, Kao SL, Huang CC, Lin CY.
    Histopathology; 1984 May 06; 8(3):435-46. PubMed ID: 6376323
    [Abstract] [Full Text] [Related]

  • 5. Pathology, clinical presentations, and outcomes of C1q nephropathy.
    Vizjak A, Ferluga D, Rozic M, Hvala A, Lindic J, Levart TK, Jurcić V, Jennette JC.
    J Am Soc Nephrol; 2008 Nov 06; 19(11):2237-44. PubMed ID: 18650484
    [Abstract] [Full Text] [Related]

  • 6. C1Q nephropathy in children.
    Kersnik Levart T, Kenda RB, Avgustin Cavić M, Ferluga D, Hvala A, Vizjak A.
    Pediatr Nephrol; 2005 Dec 06; 20(12):1756-61. PubMed ID: 16247648
    [Abstract] [Full Text] [Related]

  • 7. Immunoalkaline phosphatase technique applied to paraffin wax embedded tissues in diagnostic renal pathology.
    Jackson R, Holme ER, Phimister GM, Kennedy A, McLay AL.
    J Clin Pathol; 1990 Aug 06; 43(8):665-70. PubMed ID: 2205634
    [Abstract] [Full Text] [Related]

  • 8. Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens.
    Jennette JC, Hipp CG.
    Am J Clin Pathol; 1985 Apr 06; 83(4):415-20. PubMed ID: 3885712
    [Abstract] [Full Text] [Related]

  • 9. C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome.
    Jennette JC, Hipp CG.
    Am J Kidney Dis; 1985 Aug 06; 6(2):103-10. PubMed ID: 3875286
    [Abstract] [Full Text] [Related]

  • 10. Spontaneous improvement in a case of C1q nephropathy.
    Nishida M, Kawakatsu H, Komatsu H, Ishiwari K, Tamai M, Sawada T.
    Am J Kidney Dis; 2000 May 06; 35(5):E22. PubMed ID: 10793051
    [Abstract] [Full Text] [Related]

  • 11. [Immunopathology of nephropathy secondary to anaphylactoid purpura].
    Mota Hernández F, Alcalá O, Zúñiga V, Gordillo G.
    Bol Med Hosp Infant Mex; 1976 May 06; 33(2):385-94. PubMed ID: 769797
    [Abstract] [Full Text] [Related]

  • 12. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
    Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D'Agati VD.
    Kidney Int; 2003 Oct 06; 64(4):1232-40. PubMed ID: 12969141
    [Abstract] [Full Text] [Related]

  • 13. Value of immunofluorescence-mediated detection of Ig, C1q, C3, and FRA for the identification and diagnosis of atypical membranous nephropathy.
    Wang WX, Hu CY.
    Eur Rev Med Pharmacol Sci; 2017 Dec 06; 21(23):5415-5419. PubMed ID: 29243784
    [Abstract] [Full Text] [Related]

  • 14. Clinical significance of IgM and C1q deposition in the mesangium in pediatric idiopathic nephrotic syndrome.
    Kanemoto K, Ito H, Anzai M, Matsumura C, Kurayama H.
    J Nephrol; 2013 Dec 06; 26(2):306-14. PubMed ID: 22641570
    [Abstract] [Full Text] [Related]

  • 15. Immunohistologic features of minimal-change nephrotic syndrome.
    Prasad DR, Zimmerman SW, Burkholder PM.
    Arch Pathol Lab Med; 1977 Jul 06; 101(7):345-9. PubMed ID: 326223
    [Abstract] [Full Text] [Related]

  • 16. [Could isolated mesangial deposits of C3 be responsible of glomerular hematuric nephropathies (author's transl)].
    Saint-Andre JP, Touzard D, Houssin A, Simard C.
    Ann Pathol; 1982 Jul 06; 2(2):159-62. PubMed ID: 7104070
    [Abstract] [Full Text] [Related]

  • 17. Glomerulonephritis with organized deposits: a new clinicopathological entity? Light-, electron-microscopic and immunofluorescence study of 12 cases.
    Mazzucco G, Casanova S, Donini U, Rollino C, Zucchelli P, Piccoli G, Monga G.
    Am J Nephrol; 1990 Jul 06; 10(1):21-30. PubMed ID: 2111635
    [Abstract] [Full Text] [Related]

  • 18. Immunopathology of the end-stage kidney. Immunoglobulin and complement component deposition in nonimmune disease.
    Velosa J, Miller K, Michael AF.
    Am J Pathol; 1976 Jul 06; 84(1):149-62. PubMed ID: 779494
    [Abstract] [Full Text] [Related]

  • 19. Nephrotic syndrome with diffuse mesangial IgM deposits.
    Kobayashi Y, Shigematsu H, Tateno S, Hiki Y.
    Acta Pathol Jpn; 1982 Mar 06; 32(2):307-17. PubMed ID: 7046343
    [Abstract] [Full Text] [Related]

  • 20. Immune deposits and mesangial hypercellularity in minimal change nephrotic syndrome: clinical relevance.
    Allen WR, Travis LB, Cavallo T, Brouhard BH, Cunningham RJ.
    J Pediatr; 1982 Feb 06; 100(2):188-91. PubMed ID: 7057326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.